BRPF1 has been implicated as tumor suppressor in childhood leukemia (Huether et al., 2014), prostate cancer (Sole et al., 2020) and medulloblastoma (Kool et al., 2014). This evidence concerns the gene BRPF1 and medulloblastoma.